Celgene (CELG) to acquire privately-held biotech firm Avila Therapeutics for $350M in cash, plus...

|About: Celgene Corporation (CELG)|By:, SA News Editor

Celgene (CELG) to acquire privately-held biotech firm Avila Therapeutics for $350M in cash, plus up to $190M for milestones related to AVL-292, as well as up to $380M in potential milestone payments contingent upon the development and approval of candidates generated from the Avilomics platform. (PR)